Rheumatoid Arthritis Trial, Recruiting NCT06693479 Sponsor: Laval University Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Rheumatoid Arthritis Trial, Recruiting

NCT06693479
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who work full-time (at least 30 hours per week)
  • People experiencing shoulder problems related to their work, with symptoms severe enough to score at least 14 points on a standard shoulder disability questionnaire called the QuickDASH
  • People whose shoulder condition has been diagnosed as one of the following: rotator cuff-related shoulder pain (a problem with the tendons around the shoulder joint), shoulder osteoarthritis (wear-and-tear of the shoulder joint), or rheumatoid arthritis affecting the shoulder
  • People whose shoulder symptoms have been present for more than 6 weeks
  • For rotator cuff-related shoulder pain: a diagnosis confirmed by at least three specific physical examination findings that a doctor or clinician would assess
  • For shoulder osteoarthritis or rheumatoid arthritis: a diagnosis confirmed by a physician, based on physical examination, imaging results, or recognised diagnostic criteria

Who may not be able to join:

  • People with clinical signs of a large rotator cuff tear, such as being unable to lift the arm actively above 90 degrees while passive movement remains possible
  • People with an acute (sudden/recent) traumatic rotator cuff tear, bone fractures, a frozen shoulder (adhesive capsulitis), or shoulder instability
  • People with symptoms in the arm or hand related to nerve or blood vessel problems, such as thoracic outlet syndrome or blood clots in a vein
  • People who have previously had shoulder surgery
  • People who have received a cortisone (corticosteroid) injection in the shoulder within the past 3 months
  • People with a painful condition of the small joint at the top of the shoulder (acromioclavicular joint)
  • People currently receiving any physical or conservative treatment for their shoulder pain (note: medication for rheumatoid arthritis or osteoarthritis is not excluded)
  • People who are currently unable to work at least 30 hours per week or who are on sick leave

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Philippe Meidinger, PT, PhD student, PT, PhD student, Centre interdisciplinaire de recherche en réadaptation et intégration sociale (Cirris)

Phone: 418-529-9141

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Laval University
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 March 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Feasibility : quantitative component procedure; Feasibility : quantitative component procedure; Feasibility : quantitative component procedure; Feasibility : quantitative component procedure; Feasibility : quantitative component procedure; Feasibility : qualitative component procedure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov